World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 25 July 2023
Main ID:  NCT03764059
Date of registration: 03/12/2018
Prospective Registration: No
Primary sponsor: 3M
Public title: Clinical Study of Filtek™ Bulk Fill Posterior Restorative in Class I and II Restorations
Scientific title: A Randomized Multicenter Two-Arm Clinical Study to Evaluate the Safety and Efficacy of Filtek™ Bulk Fill Posterior Restorative in Class I and II Restorations
Date of first enrolment: October 17, 2017
Target sample size: 240
Recruitment status: Completed
URL:  https://clinicaltrials.gov/ct2/show/NCT03764059
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
China
Contacts
Name:     Xiaoyan Wang, Director
Address: 
Telephone:
Email:
Affiliation:  Endodontics department of Peking University hospital of stomatology
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Male or female,18 to 70 years old (including 18 and 70 years)

2. Good health, no significant systemic disease;

3. Normal opening degree;

4. Molar (preferred) or premolar teeth

5. Cavity type with belongs to any of the following: 1) Class I, including the failed
class I restoration which require to be repaired.; 2) Class II, including premolar and
molar except the second molar (the failed class II restoration which require to be
repaired is also included), and the gingival wall of cavity is above the free gingival
margin coronally; 3) Class II cavity on the second molar when the third molar exists,
and the gingival wall of cavity is above the free gingival margin coronally; 4) Class
II, MO or MOD cavity on the second molar when the third molar does not exist (the
failed class II restoration which require to be repaired is also included), and the
gingival wall of cavity is above the free gingival margin coronally;

6. Cavity size: the buccolingual diameter of cavity is no less than the 1/3 and of the
buccolingual cusp distance;

7. Occlusion with natural teeth;

8. Cavity depth: no less than 1/2 of dentin with a normal pulp status;

9. Be able to understand informed consent and to provide written inform consent ;

10. Be in good compliance with the protocol and willing to return to the site for follow
up visits .

Exclusion Criteria:

1. Allergy to multiple medicines; allergy to resin or other polymer material;

2. Acute caries, severe periodontitis, salivary glands malfunction, dysfunction/disorder
of TMJ (temporomandibular joint);

3. Poor oral hygiene, DMTF:18-34y >4, 35-70y >5;

4. Teeth with abnormal staining ;

5. Pathological abrasion (e.g. bruxism, clenching), acid corrosion, cracked-teeth and
other non-caries diseases.

6. Abnormal occlusion;

7. Severe systemic or mental disorders;

8. Pregnant or intended to be pregnant (pregnant test is positive ) or breast feeding
women;

9. Cavity do not meet the criteria based on the investigator's judgement;

10. Resin Composite is not an appropriate restoration for the subject

11. Pulp exposure or bottom of cavity is nearly close to the pulp;

12. Subjects who is not able to return for the one year follow-up visit because of going
abroad or other reasons;

13. Subject is enrolled in other studies on investigational drug or device

14. Cannot tolerate rubber dam isolation. -



Age minimum: 18 Years
Age maximum: 70 Years
Gender: All
Health Condition(s) or Problem(s) studied
Dental Caries Class I
Dental Caries Class II
Intervention(s)
Device: Filtek™ Z350XT Universal Restorative
Device: Filtek™ Bulk Fill Posterior Restorative
Primary Outcome(s)
Clinical Acceptance Rate of Restoration at 1 Year After Replacement [Time Frame: 1 Year after restoration]
Secondary Outcome(s)
Secondary ID(s)
MDI0102
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available: Yes
Date Posted: 21/07/2023
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT03764059
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history